Completed NA INTERVENTIONAL 2-arm NCT03317171

Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies (PRO1)

Studio Monocentrico in Doppio Cieco Randomizzato Dell'Effetto di Una Miscela di Flavonoidi ed Acidi Grassi Naturali in Pazienti Affetti da Distrofia Muscolare

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions Muscle Inflammation Muscular Dystrophies

Interventions Flavonoids, DHA, EPA placebo compound

Updated 6 times since 2017 Last updated: Oct 23, 2017 Started: Feb 28, 2016 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03317171, this NA trial focuses on Muscle Inflammation and Muscular Dystrophies and remains completed. Sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Nov 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Data source: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy